Critical Limb Ischemia Treatment Market

Direct sales is estimated to hold 49.0% of distribution channel in 2026, while hospitals are projected at 46.0% of end user and peripheral artery disease at 44.0% of application. Demand is driven by rapid perfusion restoration through coordinated limb-salvage pathways, yet delayed referral and calcified below-the-knee lesions reduce the chance of durable tissue recovery.